These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 17285115)

  • 1. The study of possibility to elevate antitumor activity and decrease of systemic toxic effects of cisplatin by its binding with deliganded albumin.
    Sakhno LA; Sarnatskaya VV; Yushko LA; Melnikov OR; Momot VY; Korneeva LN; Svintsiskiy VS; Korotich VG; Nechitaylo II; Nikolaev VG
    Exp Oncol; 2006 Dec; 28(4):303-7. PubMed ID: 17285115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role?
    Viale M; Vannozzi MO; Pastrone I; Mariggiò MA; Zicca A; Cadoni A; Cafaggi S; Tolino G; Lunardi G; Civalleri D; Lindup WE; Esposito M
    J Pharmacol Exp Ther; 2000 Jun; 293(3):829-36. PubMed ID: 10869382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deliganded albumin as a liquid adsorbent in the treatment of burn toxemia.
    Sakhno L; Sarnatskaya V; Zinovieva M; Yushko L; Maslenny V; Kozinets G; Lossitskaya V; Povstyanoy N; Nikolaev V
    Technol Health Care; 1998 Sep; 6(2-3):125-30. PubMed ID: 9839858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fortification of blood plasma from cancer patients with human serum albumin decreases the concentration of cisplatin-derived toxic hydrolysis products in vitro.
    Morris TT; Ruan Y; Lewis VA; Narendran A; Gailer J
    Metallomics; 2014 Nov; 6(11):2034-41. PubMed ID: 25255207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterosorption as a method to decrease the systemic toxicity of cisplatin.
    Sakhno LA; Yurchenko OV; Maslenniy VN; Bardakhivskaya KI; Nikolaeva VV; Ivanyuk AA; Shevchuk OO; Korotich VG; Nikolaev VG
    Exp Oncol; 2013 Mar; 35(1):45-52. PubMed ID: 23528316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human serum albumin: spectroscopic studies of the paclitaxel binding and proximity relationships with cisplatin and adriamycin.
    Trynda-Lemiesz L; Luczkowski M
    J Inorg Biochem; 2004 Nov; 98(11):1851-6. PubMed ID: 15522412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral administration of Arabic gum on cisplatin-induced nephrotoxicity in rats.
    Al-Majed AA; Abd-Allah AR; Al-Rikabi AC; Al-Shabanah OA; Mostafa AM
    J Biochem Mol Toxicol; 2003; 17(3):146-53. PubMed ID: 12815610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatin.
    Takahashi K; Seki T; Nishikawa K; Minamide S; Iwabuchi M; Ono M; Nagamine S; Horinishi H
    Jpn J Cancer Res; 1985 Jan; 76(1):68-74. PubMed ID: 3918912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats.
    Atasoyu EM; Yildiz S; Bilgi O; Cermik H; Evrenkaya R; Aktas S; Gültepe M; Kandemir EG
    Arch Toxicol; 2005 May; 79(5):289-93. PubMed ID: 15902426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
    Nersesyan A; Muradyan R; Arsenyan F
    J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium depletion enhances cisplatin-induced nephrotoxicity.
    Lajer H; Kristensen M; Hansen HH; Nielsen S; Frøkiaer J; Ostergaard LF; Christensen S; Daugaard G; Jonassen TE
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):535-42. PubMed ID: 15947931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of mitoxantrone with human serum albumin: spectroscopic and molecular modeling studies.
    Khan SN; Islam B; Yennamalli R; Sultan A; Subbarao N; Khan AU
    Eur J Pharm Sci; 2008 Dec; 35(5):371-82. PubMed ID: 18762252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients.
    Sarnatskaya VV; Yushko LA; Sakhno LA; Nikolaev VG; Nikolaev AV; Grinenko DV; Mikhalovsky SV
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(3):287-308. PubMed ID: 17573628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evaluation of S-nitrosylated human serum albumin as a novel anticancer drug.
    Katayama N; Nakajou K; Komori H; Uchida K; Yokoe J; Yasui N; Yamamoto H; Kai T; Sato M; Nakagawa T; Takeya M; Maruyama T; Otagiri M
    J Pharmacol Exp Ther; 2008 Apr; 325(1):69-76. PubMed ID: 18218831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human serum albumin adsorption on TiO2 from single protein solutions and from plasma.
    Sousa SR; Moradas-Ferreira P; Saramago B; Melo LV; Barbosa MA
    Langmuir; 2004 Oct; 20(22):9745-54. PubMed ID: 15491210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of binding constants and stoichiometries for platinum anticancer drugs and serum transport proteins by capillary electrophoresis using the Hummel-Dreyer method.
    Rudnev AV; Aleksenko SS; Semenova O; Hartinger CG; Timerbaev AR; Keppler BK
    J Sep Sci; 2005 Feb; 28(2):121-7. PubMed ID: 15754818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of O-(beta-hydroxyethyl)-rutoside on cis-platinum-induced acute renal failure in the rat.
    Dobyan DC; Bull JM; Strebel FR; Sunderland BA; Bulger RE
    Lab Invest; 1986 Nov; 55(5):557-63. PubMed ID: 3773477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.